ctbelize.com – Impact Stories & Daily Wraps

A new drug, baxdrostat, has shown promise in treating stubborn high blood pressure by blocking aldosterone production. A clinical trial involving 800 patients demonstrated that baxdrostat significantly lowered blood pressure compared to a placebo. The findings suggest that this medication could potentially benefit millions worldwide struggling with uncontrolled hypertension, offering a new avenue for effective treatment.